Dichlorodiphenyldichloroethylene
Dichlorodiphenyldichloroethylene (DDE) is a chemical compound formed by the loss of hydrogen chloride (dehydrohalogenation) from DDT, of which it is one of the more common breakdown products. It is a persistent organic pollutant (POP) that is categorized under the group of organochlorine pesticides.
Chemical Properties[edit]
DDE is a colorless crystalline solid that is practically insoluble in water but has a high affinity for fats. It is a stable compound that is resistant to acid, alkali, oxidation, and reduction. It is less volatile than DDT.
Environmental Impact[edit]
Due to its stability and fat solubility, DDE can bioaccumulate, particularly in predatory birds. DDE is toxic to a wide range of living organisms, causing adverse effects such as eggshell thinning in birds and disruptions in calcium metabolism in mammals. It is also suspected to have hormone-disrupting effects.
Health Effects[edit]
Exposure to DDE can occur through ingestion of contaminated food, inhalation, and skin contact. It can cause a variety of health effects in humans, including liver damage, nervous system damage, and reproductive effects. It is classified as a possible human carcinogen by the IARC.
Regulation[edit]
Due to its environmental and health effects, the use of DDT and its related compounds, including DDE, has been banned in many countries. It is listed in the Stockholm Convention for elimination, with specific exemptions for malaria control.
See Also[edit]
-
Chemical structure of p,p'-Dichlorodiphenyldichloroethene
-
3D model of Dichlorodiphenyldichloroethylene
-
Elimination reaction from DDT to DDE
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
